Tiludronic acid
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| {[(4-chlorophenyl)thio]methylene}bis(phosphonic acid) | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 89987-06-4  |
| ATC code | M05BA05 |
| PubChem | CID 60937 |
| DrugBank | APRD01259 |
| UNII | 6PNS59HP4Y  |
| KEGG | D08599 |
| ChEMBL | CHEMBL1350 |
| Chemical data | |
| Formula | C7H9ClO6P2S |
| Mol. mass | 318.609 g/mol |
 (what is this?) (verify) |
|
Tiludronic acid (INN; also known as tiludronate) is a bisphosphonate. It has the tradename Skelid.
[edit] Administration
Tiludronic acid is administered orally. The recommended dose is a single 400-mg daily oral dose, taken with 6 to 8 ounces of plain water only, should be administered for a period of 3 months. Beverages other than plain water (including mineral water), food (see below), and some medications are likely to reduce the tiludronic acid's absorption.
[edit] External links
|
||||||||||||||||
 |
This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it. |
